STERIS

OverviewSuggest Edit

STERIS is a global leader in infection prevention, contamination control, surgical technologies, and more.
STERIS is the world’s pre-eminent infection prevention, decontamination, and surgical and critical care company, with a long list of first-to-market products and industry-leading service innovations and thousands of customers in more than 60 countries.
While the corporation was founded as Innovative Medical Technologies in 1985 and renamed STERIS in 1987, our history dates back to 1894 with the founding of American Sterilizer Company, a long-time, global leading innovator of sterilization products.
Today, through a series of strategic acquisitions and continual innovation of new products, STERIS holds one of the broadest portfolios of products in the industry. It stands at the forefront of efforts to prevent infection and contamination in healthcare and pharmaceutical environments, and is broadening its reach with products to meet the needs of defense and industrial markets.

TypePublic
Founded1987
HQMentor, USMap
Websitesteris.com
Employee Ratings3.3More
View Jobs (486)

Recent NewsAll News

Latest Updates

Employees (est.) (Feb 2019)12,000
Job Openings486
Revenue (FY, 2018)$2.6 B
Share Price (Oct 2019)$142.4

STERIS Office Locations

STERIS has offices in Mentor, Birmingham, Chester, Chesterfield and in 71 other locations
Mentor, US (HQ)
5960 Heisley Rd
Birmingham, US
3316 2nd Ave N
Chester, US
23 Elizabeth Dr
Chesterfield, US
515 Trade Center Blvd
Coon Rapids, US
380 90th Ave NW
Cooper City, US
12229 SW 53rd St
Show all (92)

STERIS Financials and Metrics

STERIS Revenue

Embed Graph
View revenue for all periods
STERIS's revenue was reported to be $2.62 b in FY, 2018
USD

Revenue (Q2, 2019)

679.0m

Gross profit (Q2, 2019)

284.7m

Gross profit margin (Q2, 2019), %

41.9%

Net income (Q2, 2019)

77.5m

EBIT (Q2, 2019)

106.6m

Market capitalization (16-Oct-2019)

12.1b

Closing stock price (16-Oct-2019)

142.4

Cash (30-Sep-2018)

209.9m
STERIS's current market capitalization is $12.1 b.
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Revenue

1.6b1.9b2.2b2.6b2.6b

Revenue growth, %

14%21%17%

Cost of goods sold

972.6m1.1b1.3b1.6b1.5b

Gross profit

649.6m774.3m895.5m1.0b1.1b
Quarterly
USDQ3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Revenue

618.7m638.4m646.4m646.8m608.0m634.2m661.9m638.8m679.0m

Cost of goods sold

380.5m398.4m398.5m389.2m351.8m367.4m383.3m369.7m394.3m

Gross profit

238.2m240.0m247.9m257.6m256.1m266.8m278.6m269.1m284.7m

Gross profit Margin, %

38%38%38%40%42%42%42%42%42%
show all
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Cash

152.8m167.7m248.8m282.9m201.5m

Accounts Receivable

313.7m325.3m471.5m483.5m528.1m

Inventories

37.0m35.0m59.4m197.8m205.7m

Current Assets

674.7m720.4m972.5m1.0b989.7m
Quarterly
USDQ3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Cash

231.4m242.4m254.4m264.9m294.8m295.6m283.8m218.5m209.9m

Accounts Receivable

440.9m439.8m441.3m443.7m455.6m449.4m472.1m481.5m491.0m

Inventories

208.3m209.6m209.9m209.7m217.4m224.8m219.5m233.9m230.8m

Current Assets

965.7m945.9m956.2m970.3m1.0b1.0b1.0b988.9m979.5m
show all
Annual
USDFY, 2014FY, 2015FY, 2016FY, 2017FY, 2018

Net Income

129.4m135.1m110.8m110.0m

Inventories

(12.8m)(5.2m)

Accounts Payable

19.4m(3.1m)5.2m6.9m563.0k

Cash From Operating Activities

209.6m246.0m81.2m424.1m457.6m
Quarterly
USDQ3, 2016Q1, 2017Q2, 2017Q3, 2017Q1, 2018Q2, 2018Q3, 2018Q1, 2019Q2, 2019

Net Income

20.0m48.4m88.9m84.6m58.2m122.7m218.0m70.3m147.8m

Inventories

(15.5m)(19.8m)(21.7m)(27.4m)(15.8m)(19.0m)(21.6m)(34.1m)(33.0m)

Accounts Payable

(17.9m)(13.2m)(17.0m)(5.8m)(10.2m)(8.6m)(10.6m)(1.9m)(7.4m)

Cash From Operating Activities

104.6m80.3m188.5m289.4m80.7m217.4m327.9m100.8m226.7m
show all
USDY, 2018

Financial Leverage

1.6 x
Show all financial metrics

STERIS Operating Metrics

FY, 2016

Patents (Foreign)

1.10 k

Patents (US)

390

Patents Pending

470
Show all operating metrics

STERIS Revenue Breakdown

Embed Graph

STERIS revenue breakdown by business segment: 27.4% from Capital equipment, 23.1% from Consumable and 49.5% from Service

STERIS Online and Social Media Presence

STERIS's Trends

Embed Graph

STERIS News and Updates

August 05, 2019

STERIS Announces Financial Results for Fiscal 2020 First Quarter

• First quarter revenue grows 9% as reported, 10% constant currency organic revenue growth; • EPS as reported increases to $0.99, adjusted EPS increases to $1.23; • Outlook updated to reflect stronger than anticipated performance • First quarter revenue grows 9% as reported, 10% constant currency or…
July 23, 2019

STERIS to Host a Conference Call for Fiscal 2020 First Quarter Financial Results on August 6, 2019

Dublin, Ireland, July 23, 2019 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2020 first quarter financial results at 10:00 a.m. Eastern Time on Tuesday, August 6, 2019.  The conference call can be he…
May 13, 2019

STERIS Announces Financial Results for Fiscal 2019 Fourth Quarter and Full Year

Dublin, Ireland, May 13, 2019 (GLOBE NEWSWIRE) -- - STERIS plc (NYSE: STE) (“STERIS” or the “Company”) today announced financial results for its fiscal 2019 fourth quarter ended March 31, 2019.  Revenue as reported for the quarter increased 7% to $768.2 million compared with $716.0 million in the …
April 30, 2019

STERIS to Host a Conference Call for Fiscal 2019 Fourth Quarter and Full Year Financial Results on May 14, 2019

DUBLIN, Ireland, April 30, 2019 (GLOBE NEWSWIRE) -- STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2019 fourth quarter and full year financial results at 10:00 a.m. Eastern Time on Tuesday, May 14, 2019. The conference c…
January 16, 2019

Medical Image Management Market to Witness Huge Growth by 2025 | Olympus, Boston Scientific, Cook Medical, CONMED Corporation, Medline Industries, Medtronic, Steris

The Global Medical Image Management Market Report includes a comprehensive analysis of the present market. The report starts with the basic overview for this market and then goes into each and every detail. Posted via Industry Today. Follow us on Twitter @IndustryToday
January 11, 2019

Heat Sterilization Equipment Market Emerging Trends and Massive Growth by Top key players like Armstrong International, 3M Company, TSO3, Cardinal Health, Steris

Heat Sterilization Equipment Market, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. Pos…
Show more

 STERIS Frequently Asked Questions

  • When was STERIS founded?

    STERIS was founded in 1987.

  • How many employees does STERIS have?

    STERIS has 12,000 employees.

  • What is STERIS revenue?

    Latest STERIS annual revenue is $2.6 b.

  • What is STERIS revenue per employee?

    Latest STERIS revenue per employee is $218.3 k.

  • Who are STERIS competitors?

    Competitors of STERIS include Stryker, Cantel Medical and Xenex Disinfection Services.

  • Where is STERIS headquarters?

    STERIS headquarters is located at 5960 Heisley Rd, Mentor.

  • Where are STERIS offices?

    STERIS has offices in Mentor, Birmingham, Chester, Chesterfield and in 71 other locations.

  • How many offices does STERIS have?

    STERIS has 92 offices.